Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxol-BEP versus BEP in intermediate prognosis germ cell cancer
2004-000731-28Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of paclitaxel, cisplatin, etoposide and bleomycin in germ cell tumor (GCT) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Started Feb 2006; status: completed.
02
Drugs
paclitaxelcisplatinetoposidebleomycin
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on 2004-000731-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000731-28.